Pathway Diagnostics: Biomarker Development, Testing and Commercialization Ask Us How

Corporate

Partners

Pathway Diagnostics partners with pharmaceutical and biotechnology companies, academia and the in vitro diagnostic industry to develop and commercialize technology and biomarkers.

For pharmaceutical and biotechnology firms that want to develop a companion diagnostic, we help to design and format assays in a manner that suits future testing in a routine reference laboratory environment. We then work together with diagnostic assay companies to move those assays to specific instrument platforms.

For commercial and academic institutions wishing to take biomarker development programs to the next level, we offer strategic partnering opportunities. We are interested in evaluating in-licensing and collaborative opportunities in the major areas of focus: cardiovascular diseases, oncology, inflammatory and autoimmune diseases, infectious diseases and psychiatric disorders.

Pathway Diagnostics is a provider of the CellSearch System, distributed by Veridex and is on Veridex's recommended providers list.

 

What's New "Announcing SensiTrop™ II HIV co-receptor tropism assay, combining the sensitivity of heteroduplex tracking and the specificity of DNA sequence analysis "
©2007 PathwayDX.com. Privacy Policy.